All Stories

  1. Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia
  2. Complement 3 Is a Potential Biomarker for Cerebral Amyloid Angiopathy
  3. Drug Repositioning for Alzheimer’s Disease: Finding Hidden Clues in Old Drugs
  4. Visually-Rated Medial Temporal Lobe Atrophy with Lower Educational History as a Quick Indicator of Amnestic Cognitive Impairment after Stroke
  5. Collagen-binding Streptococcus mutans tied to cerebral microbleeds and intracerebral hemorrhage
  6. Swallowing-induced displacement of the carotid artery as a risk of stroke: Flip-flop phenomenon
  7. Stroke and other cerebrovascular diseases
  8. Post-stroke epilepsy
  9. Disruption of transforming growth factor-β superfamily signaling: A shared mechanism underlying hereditary cerebral small vessel disease
  10. Cerebral hyperperfusion on arterial spin labeling MRI after reperfusion therapy is related to hemorrhagic transformation
  11. Long-term cilostazol treatment reduces gliovascular damage and memory impairment in a mouse model of chronic cerebral hypoperfusion
  12. Pericyte-derived bone morphogenetic protein 4 underlies white matter damage after chronic hypoperfusion
  13. Effects of environmental enrichment on white matter glial responses in a mouse model of chronic cerebral hypoperfusion
  14. The effects of environmental enrichment on white matter pathology in a mouse model of chronic cerebral hypoperfusion
  15. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects
  16. Mild intrauterine hypoperfusion reproduces neurodevelopmental disorders observed in prematurity
  17. How Commonly Is Stroke Found in Patients with Isolated Vertigo or Dizziness Attack?
  18. Highly Selective Tau-SPECT Imaging Probes for Detection of Neurofibrillary Tangles in Alzheimer’s Disease
  19. Novel Bivalent 99mTc-Complex with N-Methyl-Substituted Hydroxamamide as Probe for Imaging of Cerebral Amyloid Angiopathy
  20. Right parietal source in Mahjong‐induced seizure: a system epilepsy of focal origin
  21. Substantial Reduction of Parenchymal Cerebral Blood Flow in Mice with Bilateral Common Carotid Artery Stenosis
  22. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy with a Novel NOTCH3 Cys323Trp Mutation Presenting Border-Zone Infarcts: A Case Report and Literature Review
  23. Influence of Low-Dose Aspirin on Cerebral Amyloid Angiopathy in Mice
  24. Imaging of Cerebral Amyloid Angiopathy with Bivalent 99mTc-Hydroxamamide Complexes
  25. Comment: Autosomal dominant small vessel disease due to heterozygousHTRA1mutations
  26. Hemisphere Asymmetry of Response to Pharmacologic Treatment in an Alzheimer’s Disease Mouse Model
  27. Interaction between cerebrovascular disease and Alzheimer pathology
  28. Intracerebral hemorrhage and deep microbleeds associated with cnm-positive Streptococcus mutans; a hospital cohort study
  29. Gradual Carotid Artery Stenosis in Mice Closely Replicates Hypoperfusive Vascular Dementia in Humans
  30. Emerging Evidence for Pathogenesis of Sporadic Cerebral Small Vessel Disease
  31. Seizure Outcomes and Predictors of Recurrent Post-Stroke Seizure: A Retrospective Observational Cohort Study
  32. Mild Cognitive Impairment: At the Crossroad of Neurodegeneration and Vascular Dysfunction
  33. Adrenomedullin promotes differentiation of oligodendrocyte precursor cells into myelin-basic-protein expressing oligodendrocytes under pathological conditions in vitro
  34. Intracranial Cerebral Artery Dissection of Anterior Circulation as a Cause of Convexity Subarachnoid Hemorrhage
  35. Potential interactions between pericytes and oligodendrocyte precursor cells in perivascular regions of cerebral white matter
  36. SIRT1 attenuates severe ischemic damage by preserving cerebral blood flow
  37. Synthesis and biological evaluation of 123I-labeled pyridyl benzoxazole derivatives: novel β-amyloid imaging probes for single-photon emission computed tomography
  38. Evaluation of Angiogenesis and Arteriogenesis in a Mouse Model of Prolonged Cerebral Hypoperfusion
  39. Lessons learned from animal models of vascular cognitive impairment
  40. New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
  41. Motor and cognitive impairment in a mouse model of ischemic carotid artery disease
  42. Association of the ASCO Classification with the Executive Function Subscores of the Montreal Cognitive Assessment in Patients with Postischemic Stroke
  43. Silent Information Regulator 2 Homolog 1 Counters Cerebral Hypoperfusion Injury by Deacetylating Endothelial Nitric Oxide Synthase
  44. Possible paraneoplastic etiology in a case of Guillain-Barré syndrome with tumoral expression of ganglioside GM3
  45. Understanding and preventing the development of post-stroke dementia
  46. Oligodendrocyte Precursor Cells Support Blood-Brain Barrier Integrity via TGF-β Signaling
  47. Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β‐amyloid
  48. Gluten Ataxia in Japan
  49. White matter pathology and disconnection in the frontal lobe in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
  50. A Novel Mouse Model of Ischemic Carotid Artery Disease
  51. Validation of Ultrasound Parameters to Assess Collateral Flow via Ophthalmic Artery in Internal Carotid Artery Occlusion
  52. Cilostazol Add-On Therapy in Patients with Mild Dementia Receiving Donepezil: A Retrospective Study
  53. Novel radioiodinated 1,3,4-oxadiazole derivatives with improved in vivo properties for SPECT imaging of β-amyloid plaques
  54. A Mouse Model of Chronic Cerebral Hypoperfusion Characterizing Features of Vascular Cognitive Impairment
  55. XIAP immunoreactivity in glial and neuronal cytoplasmic inclusions in multiple system atrophy
  56. Association of Physical Activity with the Visuospatial/Executive Functions of the Montreal Cognitive Assessment in Patients with Vascular Cognitive Impairment
  57. Development of Novel 123I-Labeled Pyridyl Benzofuran Derivatives for SPECT Imaging of β-Amyloid Plaques in Alzheimer’s Disease
  58. Vascular and neurodegenerative pathways—will they meet?
  59. Suitability of the Montreal Cognitive Assessment versus the Mini-Mental State Examination in Detecting Vascular Cognitive Impairment
  60. A highly reproducible model of cerebral ischemia/reperfusion with extended survival in CB-17 mice
  61. Vascular Risk Factors and Neurodegeneration in Ageing Related Dementias: Alzheimer’s Disease and Vascular Dementia
  62. Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis
  63. Synthesis and biological evaluation of novel styryl benzimidazole derivatives as probes for imaging of neurofibrillary tangles in Alzheimer’s disease
  64. Structure–Activity Relationships and in Vivo Evaluation of Quinoxaline Derivatives for PET Imaging of β-Amyloid Plaques
  65. Experimental Evidence and Early Translational Steps Using Bone Marrow Derived Stem Cells after Human Stroke
  66. Does vascular pathology contribute to Alzheimer changes?
  67. In Vivo Imaging of Brain Ischemia Using an Oxygen-Dependent Degradative Fusion Protein Probe
  68. Synthesis and biological evaluation of novel oxindole derivatives for imaging neurofibrillary tangles in Alzheimer’s disease
  69. Novel 18F-Labeled Benzoxazole Derivatives as Potential Positron Emission Tomography Probes for Imaging of Cerebral β-Amyloid Plaques in Alzheimer’s Disease
  70. Selective white matter abnormalities in a novel rat model of vascular dementia
  71. Environmental enrichment ameliorated high-fat diet-induced Aβ deposition and memory deficit in APP transgenic mice
  72. Immunohistochemical localization of X-linked inhibitor of apoptosis protein in brainstem-type and cortical Lewy bodies
  73. Case report of transthyretin Val30Met familial amyloid polyneuropathy presenting hydrocephalus
  74. A Case of Follicular Lymphoma Associated with Paraneoplastic Cerebellar Degeneration
  75. Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia
  76. Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts
  77. Selective white matter pathology induces a specific impairment in spatial working memory
  78. 18F-Labeled Phenyldiazenyl Benzothiazole for in Vivo Imaging of Neurofibrillary Tangles in Alzheimer's Disease Brains
  79. Environmental Enrichment ameliorates high fat diet induced memory deficit and β-amyloidosis
  80. Watershed infarcts in a multiple microembolic model of monkey
  81. Angiogenic roles of adrenomedullin through vascular endothelial growth factor induction
  82. Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation
  83. Colocalization of 14-3-3 Proteins with SOD1 in Lewy Body-Like Hyaline Inclusions in Familial Amyotrophic Lateral Sclerosis Cases and the Animal Model
  84. Rhodanine and Thiohydantoin Derivatives for Detecting Tau Pathology in Alzheimer’s Brains
  85. The Influence of Chronic Cerebral Hypoperfusion on Cognitive Function and Amyloid β Metabolism in APP Overexpressing Mice
  86. Phenyldiazenyl benzothiazole derivatives as probes for in vivo imaging of neurofibrillary tangles in Alzheimer's disease brains
  87. Lessons from a Mouse Model Characterizing Features of Vascular Cognitive Impairment with White Matter Changes
  88. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer’s disease, and dementia with Lewy bodies
  89. Pathophysiology of vascular cognitive impairment
  90. A Novel Rat Model of Vascular Dementia with Ameroid Constrictor
  91. Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to PPAR-γ activation in mice with chronic cerebral hypoperfusion
  92. A case of branch atheromatous disease presenting with neuropsychiatric symptoms without any apparent sensorimotor deficits
  93. Intravenous recombinant tissue plasminogen activator in an 18-weeks pregnant woman with embolic stroke
  94. Chronic cerebral hypoperfusion accelerates amyloid β deposition in APPSwInd transgenic mice
  95. Cortical microinfarcts in Alzheimer's disease and subcortical vascular dementia
  96. P2‐197: Chronic cerebral hypoperfusion causes myelin damage and is associated with a selective impairment in working memory
  97. A novel approach to vascular regeneration in subcortical vascular dementia
  98. The effect of vascular progenitor cells on chronic cerebral hypoperfusion mouse model
  99. Intravenously administered bone marrow cells alleviates white matter lesions in a model of chronic cerebral hypoperfusion
  100. Adrenomedullin preserves white matter integrity after chronic cerebral hypoperfusion in mice
  101. Leukoencephalopathy with Cognitive Impairment following Tocilizumab for the Treatment of Rheumatoid Arthritis (RA)
  102. Septins as Diagnostic Markers for a Subset of Human Asthenozoospermia
  103. Functional imaging in Binswanger's disease
  104. Amyloid-β and synaptic activity in mice and men
  105. Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease
  106. Sept4, a Component of Presynaptic Scaffold and Lewy Bodies, Is Required for the Suppression of α-Synuclein Neurotoxicity
  107. Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of α-synuclein neurotoxicity
  108. α-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice
  109. Gluten Sensitivity in Japanese Patients with Adultonset Cerebellar Ataxia
  110. Small Artery Dementia in Japan: Radiological Differences between CADASIL, Leukoaraiosis and Binswanger’s Disease
  111. Chronic cerebral hypoperfusion induces white matter lesions and cognitive abnormalities; a comparison between mouse and rat models for vascular dementia
  112. Possible cortico-subcortical motor circuit disruption in patients with vascular parkinsonism
  113. Cortical Organization by the Septin Cytoskeleton Is Essential for Structural and Mechanical Integrity of Mammalian Spermatozoa
  114. Loss of Cholinergic Pathways in Vascular Dementia of the Binswanger Type
  115. Different mechanisms of corpus callosum atrophy in Alzheimer?s disease and vascular dementia
  116. Ibudilast, a phosphodiesterase inhibitor, protects against white matter damage under chronic cerebral hypoperfusion in the rat
  117. Association of the Cytoskeletal GTP-binding Protein Sept4/H5 with Cytoplasmic Inclusions Found in Parkinson's Disease and Other Synucleinopathies
  118. Unequal Crossing-over in Unique PABP2 Mutations in Japanese Patients
  119. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat
  120. Delayed synaptic dysfunction of association cortices in carbon monoxide intoxication
  121. Chronic Cerebral Hypoperfusion Induces MMP-2 but Not MMP-9 Expression in the Microglia and Vascular Endothelium of White Matter
  122. Identification of human endomucin-1 and -2 as membrane-boundO-sialoglycoproteins with anti-adhesive activity1
  123. Serial Transcranial Color-Coded Sonography in Postpartum Cerebral Angiopathy
  124. Wernicke’s encephalopathy associated with hemodialysis: report of two cases and review of the literature
  125. Primary Antiphospholipi Syndrome with Recurrent Transient Ischemic Attacks: Report of a Case and Its Successful Treatment.
  126. A case of middle cerebral artery branch recanalization evaluated by transcranial color flow imaging.
  127. Two cases of ischemic cerebrovascular disease associated with hereditary protein C deficiency.